Back to search

University of Peloponesse

Διαταραχές λιπιδίων και λιποπρωτεϊνών σε ασθενείς με κακοήθη νεοπλάσματα μαστού κατά τη διάρκεια της χημειοθεραπείας

Abstract

dc:description

Introduction: Breast cancer is a major public health problem and the most common cancer in women. New treatment had led to improved outcomes and increased patient survival. Although chemotherapy is necessary to improve disease-free survival as well as the overall survival of patients, it is associated with long-term side effects, including cardiovascular diseases. Cardiovascular diseases are common complications after chemotherapy due to the direct cardio toxicity of chemotherapeutic drugs as well as drugs effect on lipid levels. Purpose: To monitor the change in lipid profile in breast cancer patients under chemotherapy in relation to the response to treatment. Methodology: This is a prospective study involving patients with independent stage of breast cancer from 2018 to 2020. Three consecutive measurements were performed and a biochemical-lipid hematological test was performed: glucose, total cholesterol, triglycerides, HDL, LDL, total proteins, albumin, σφαιρίνη, ApoA, ApoB and Lp(a) before initiation, at baseline, and during the last chemotherapy of the first regimen. Statistical significance was set at p<0.05 and analyses were conducted using SPSS statistical software (version 22.0).Results: Mean age of breast cancer patients was 60.4 years (SD=11.3 years) and the mean BMI was 29.5 kgr/m2 (SD=5.5 kgr/m2). Also, 16.0% of the participants had normal BMI, 46.0% were overweight and 38.0% were obese. Glucose increased significantly at 1st follow-up in comparison to the correspondent pre-therapy percentage and continued to increase significantly at the 2nd follow-up in comparison to the 1st follow-up. Overall, from the pre-therapy measurement to the 2nd follow-up glucose increased significantly. Total protein values albumin and globulin did not change significantly throughout the follow-up period nor their percentages of pathological values. The percentages of participants with pathological total protein were significantly higher at 1st and at 2nd protein in comparison to the correspondent pre-therapy percentage. Mean cholesterol values increased significantly from pre-therapy to 2nd follow-up. Triglycerides values before treatment were similar to the values in the 1st and 2nd follow-up. However, triglycerides decreased significantly from 1st to 2nd follow-up. Furthermore, HDL was significantly lower at 1st follow-up compared to pre-therapy and to 2nd follow-up reaching similar to the initial levels. LDL values were significantly greater at 2nd follow-up compared to pre-therapy measurement. The percentages of pathological levels were similar across the follow up period. ApoA and Lp(a) values did not change significantly over follow-up period. ApoB values before treatment and during the 1st follow-up were similar. ApoB values were significantly higher at 2nd follow-up compared to pre-therapy measurement and the percentage of pathological ApoB was significantly at 2nd follow-up compared to 1st follow-up. ApoB/ApoA values were significantly higher at 1st follow-up compared to pre-therapy measurement remained at similar levels until the 2nd follow-up. Correlation analysis showed a significant and negative correlation of BMI with albumin at pre-therapy measurement, albumin at 1st follow-up and a significant and positive correlation of BMI with globulin at pre-therapy measurement, LDL at pre-therapy measurement, cholesterol at 1st follow-up, LDL at 1st follow-up, APOB/APOA, cholesterol at 2nd follow-up, LDL at 2nd follow-up και APOB/APOA at 2nd follow-up. Conclusions: In breast cancer during chemotherapy there is a statistically significant increase in the levels of cholesterol, LDL, ApoB, APOB / APOA ratio and glucose. In other words, there is a disorder of lipids and lipoproteins, which highlights the need to monitor the lipid profile of breast cancer patients in order to reduce the risk of developing cardiovascular risk factors and receive the optimal therapeutic effect.

Degree

thesis:*
Grantor dc:publisher
University of Peloponesse
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Aliberti, Aikaterini
  • Αλιμπέρτη, Αικατερίνη

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52959

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Aliberti, Aikaterini; Αλιμπέρτη, Αικατερίνη. Διαταραχές λιπιδίων και λιποπρωτεϊνών σε ασθενείς με κακοήθη νεοπλάσματα μαστού κατά τη διάρκεια της χημειοθεραπείας. University of Peloponesse, 2022. http://hdl.handle.net/10442/hedi/52959